NCT02889744

Brief Summary

The investigators hypothesize that

  1. 1.if decrease in SctO2 level is caused by the degree of hypothermia, SctO2 level in the 33-TH may be lower than that in the 36-TH group.
  2. 2.if decrease in SctO2 level is not caused by the degree of hypothermia but caused by brain injury, SctO2 level may be associated with only the prognosis of cardiac arrest victims regardless of core temperatures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2016

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 7, 2016

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

March 18, 2021

Status Verified

March 1, 2021

Enrollment Period

4.3 years

First QC Date

August 18, 2016

Last Update Submit

March 16, 2021

Conditions

Keywords

TemperatureHypothermiaBrainOxygenPrognosis

Outcome Measures

Primary Outcomes (1)

  • The comparison of the 72-hour SctO2 level between the 36-TH and 33-TH groups in cardiac arrest victims

    72 hour

Secondary Outcomes (6)

  • The comparison of the 72-hour changes in SctO2 level between the 36-TH and 33-TH groups

    0, 24, and 72 hours

  • The comparison of the severity scores between the 36-TH and 33-TH groups

    0, 24, and 72 hours

  • The comparison of the serum biomarker levels between the 36-TH and 33-TH groups

    0, 24, and 72 hours

  • The comparison of the number of patients with survival discharge between the 36-TH and 33-TH groups

    6 months

  • The comparison of the 6-month cerebral performance scale (CPC) between the 36-TH and 33-TH groups

    6 months

  • +1 more secondary outcomes

Study Arms (2)

36-TH

ACTIVE COMPARATOR

Core temperature 36℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.

Device: Arctic Sun

33-TH

ACTIVE COMPARATOR

Core temperature 33℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.

Device: Arctic Sun

Interventions

Targeted temperature management for 24 hours with core temperature 36℃ or 33℃

Also known as: External cooling device
33-TH36-TH

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Comatose patients successfully resuscitated from cardiac arrest

You may not qualify if:

  • \< 18 years old
  • Definite non-cardiac cause arrest
  • Contraindication to TH Active bleeding, coagulopathy, fatal arrhythmia, severe infectious condition
  • Presence of advanced directives to withhold or withdraw life-sustaining treatment
  • Expected survival \< 72 hours
  • Underlying low CPC (≤ 3)
  • No informed consent
  • Follow-up loss

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

Related Publications (5)

  • Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002 Feb 21;346(8):549-56. doi: 10.1056/NEJMoa012689.

    PMID: 11856793BACKGROUND
  • Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Aneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Kober L, Langorgen J, Lilja G, Moller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H; TTM Trial Investigators. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013 Dec 5;369(23):2197-206. doi: 10.1056/NEJMoa1310519. Epub 2013 Nov 17.

    PMID: 24237006BACKGROUND
  • Buunk G, van der Hoeven JG, Meinders AE. A comparison of near-infrared spectroscopy and jugular bulb oximetry in comatose patients resuscitated from a cardiac arrest. Anaesthesia. 1998 Jan;53(1):13-9. doi: 10.1111/j.1365-2044.1998.00263.x.

  • Suffoletto B, Kristan J, Rittenberger JC, Guyette F, Hostler D, Callaway C. Near-infrared spectroscopy in post-cardiac arrest patients undergoing therapeutic hypothermia. Resuscitation. 2012 Aug;83(8):986-90. doi: 10.1016/j.resuscitation.2012.03.021. Epub 2012 Apr 19.

  • Meex I, Dens J, Jans F, Boer W, Vanhengel K, Vundelinckx G, Heylen R, De Deyne C. Cerebral tissue oxygen saturation during therapeutic hypothermia in post-cardiac arrest patients. Resuscitation. 2013 Jun;84(6):788-93. doi: 10.1016/j.resuscitation.2013.01.003. Epub 2013 Jan 8.

MeSH Terms

Conditions

Heart ArrestHypothermia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gil Joon Suh, MD, PhD

    Seoul National Univerisity College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Primary and secondary outcomes were assessed by an investigator blinded to this study.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: From the results of previous studies, we assumed that the mean difference in rSO2 at 72 h between the 36℃ or 33℃ groups would be 3% with 4% of standard deviation. By a referral (2015-0207) to the Medical Research Collaborating Center (MRCC) of SNUH/SNUMC, a sample size of at least 58 (29 per group) was calculated with a power of 0.8 and a significance level of 0.05. Considering an unexpected loss of 15%, the study was planned for 66 participants. Randomization was performed by the 4, 6-block randomization method at the MRCC SNUH/SNUMC web-site (http://mrcc.snu.ac.kr).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2016

First Posted

September 7, 2016

Study Start

March 1, 2016

Primary Completion

July 1, 2020

Study Completion

March 1, 2021

Last Updated

March 18, 2021

Record last verified: 2021-03

Locations